A protein commonly found at high levels in lung cancer cells controls a major immunosuppressive pathway that allows lung tumors to evade immune attack, according to a study led by researchers at Weill Cornell Medicine.
The National Institute on Aging of the National Institutes of Health has awarded a grant to Weill Cornell Medicine to develop a screening tool and intervention for elder neglect in patients with Alzheimer’s disease and related dementias.
A novel combination of artificial intelligence and production techniques could change the future of nanomedicine, according to Cornell researchers using a new $3 million grant from the National Science Foundation to revolutionize how polymer nanoparticles are manufactured.
A new method can illuminate the identities and activities of cells throughout an organ or a tumor at unprecedented resolution, according to a study co-led by researchers at Weill Cornell Medicine and the New York Genome Center.
The researchers used a machine-learning algorithm to spot symptom patterns in the health records of nearly 35,000 U.S. patients who tested positive for SARS-CoV-2 infection and later developed lingering long-COVID-type symptoms.
The funding will support preliminary disease-related research, in the latest in a series of efforts to create new opportunities for interdisciplinary research.
Celebrating graduation and each other, students in the Executive Master of Health Administration and Executive Master of Public Administration programs at the Cornell Jeb E. Brooks School of Public Policy received diplomas at a joyful ceremony in Willard Straight Hall.
An artificial intelligence algorithm can determine non-invasively, with about 70% accuracy, if an in vitro fertilized embryo has a normal or abnormal number of chromosomes, according to a new study from researchers at Weill Cornell Medicine.
